Conversion of AA 21 Nucleotide synth 22 Flashcards
Porphyrins
Heme
cyclic compounds that readily bind metal ions
- usually Fe2+ or Fe3+
- formed by linkage of 4 pyrrole rings
Heme is one Fe2+ (ferrous) ion corrdinated in center of ring of protoporphyrin IX
The major site of heme biosynthesis is in the ____ and ____.
liver, erythrocyte producing cells of bone marrow
bone marrow active in Hb synthesis
The formation of ALA (d-aminolevulinic acid)
- requires what as a coenzyme
- why is this step imp
All Cs and Ns of the porphyrin molecule are provided by glycine(AA) and succinyl coA (TCA) via ALA synthase (ALAS)
Requires PLP as a coenzyme
1st step of Heme biosynthesis
Rate committed and RLS in porphyrin biosynthesis
Administration of drugs (increases/decreases) ALA synthase activity?
increase significantly
Drugs metabolized by P450 system
- (a hemeprotein oxidase system found in liver)
- In response to drugs, the synthesis of cytochrome P450 proteins ↑
- Enhanced consumption of heme
- Causes decrease in the [ heme ] in liver cells
- Lower intracellular [ heme ] → increase in ALAS1 → ALA synthesis
Why is ALA elevated and anemia seen in lead poisoning?
Condensation of two molecules of ALA → porphobilinogen is extremely sensitive to inhibition by heavy metal ions
Last 2 steps of heme synthesis
Copro-porphyrin-ogen III → Proto-porphyrin IX
Fe2+ (ferrous) ion binds spontaneously, but enhanced by ferrochelatase
Proto-porphyrin IX → Heme
Porphyrias
- common feature
- most common one (describe)
common feature: ↓ synthesis of heme
Accumulation of ALAS1 and toxic intermediates to compensate
Most common porphyria: Porphyria Cutanea Tardia
- deficiency in uroporphyrinogen decarboxylase (cant convert Uro-porphyrinogen III→ Co-proporphyrinogen III)
- patients are photosensitive
Degradation of heme → yellow urobilin + brown stercobilin
- Senescent (120 day old) RBCs are taken up and HEME is broken down to BILIRUBIN by macrophages of reticuloendothelial system (tissue macrophages, spleen, liver)
- BILIRUBIN binds to albumin and gets transported to liver, where it dissociates and enters hepatocytes
- BILIRUBIN is conjugated with glucuronic acid → BILIRUBIN DIGLUCORONIDE (more soluble)
- It is then transported into bile then intestine
- Intestinal bacteria removes glucuronic acid → UROBILINOGEN
- It can then go to the kidney → yellow urobilin (yellow pee)
Or it can stay in intestine → brown stercobilin
*this is why high levels of unconjugated bili is bad
PRPP
- what is it
- what does it do?
- how is it made
- Does Pi and purine ribonucleotides activate or inactivate it?
an “activate pentose” that participates in the synthesis and salvage of purines and pyrimidines.
PRPP is made from ATP and Ribose 5 P (HMPP)
Pi activates PRPP synthesis
Purine ribonucleotide inhibits
Committed step of purine nucleotide biosynthesis
- Which on activates and inhibits this step:
AMP, GMP, PRPP
Synthesis of 5’-phosphoribosylamine from PRPP + glutamine
(amide group of glutamine replaces pyrophosphate group of PRPP)
Activator: PRPP
Inhibitor: AMP, GMP (end products in pathway)
Nucleotide biosynthesis of IMP
the “parent” purine nucleotide
PRPP +4 ATP→ → → IMP
Folic acid analogs and what do they do
Methotrexate
inhibit the reduction of dihydrofolate to tetrahydrofolate
(competitive inhibitor to hihydrofolate reductase)
- they limit the amt of THF available for use in purine synthesis and slow down DNA replication in mammal cells.
- Useful in treating rapidly growing cancers!
- INTERFERES WITH PURINE SYNTHESIS
PABA anologs and what they do
- what does it require as a coenzyme?
- do they interfere with purine synthesis?
Sulfonamides
Competitively inhibit bacterial synthesis of folic acid.
Purine synthesis requires THF as coenzyme, and sulfa drugs slow it down.
- DO NOT INTERFERE WITH HUMAN PURINE SYNTHESIS
Conversion of IMP to AMP and GMP. What E sources do each of them need?
IMP →AMP : needs GTP
IMP → GMP : needs ATP
Both AMP and GMP are the end products that inhibit the first steps in both pathways
- that way IMP makes more of which ever one is needed more
Mycophenolic acid
The drug is a reversible inhibitor of IMP dehydrogenase which catalyzes the first step in IMP → GMP synthesis
- deprives rapidly proliferating T + B cells of nucleic acid components
- good 4 immunosuppressants